Skip to main content
Dabur India Ltd. logo

Dabur India Ltd. — Investor Relations & Filings

Ticker · DABUR ISIN · INE016A01026 LEI · 335800MJPUA2E1FSFL38 BSE.NS Manufacturing
Filings indexed 2,046 across all filing types
Latest filing 2024-05-02 Regulatory Filings
Country IN India
Listing BSE.NS DABUR

About Dabur India Ltd.

https://www.dabur.com

Dabur India Ltd. specializes in Ayurvedic and natural healthcare solutions, managing a diverse portfolio across health supplements, oral care, hair care, skin care, home care, and food and beverages. Established in 1884, the organization integrates traditional Ayurvedic wisdom with modern scientific research to develop standardized herbal products. Key brands include Dabur Chyawanprash, Dabur Honey, Real fruit juices, Vatika, and Dabur Red Paste. The company maintains a robust research and development framework to support its focus on natural ingredients and holistic health. Its operations serve a wide demographic across international markets, emphasizing the synergy between nature and science through an extensive distribution network and a commitment to quality-driven consumer products.

Recent filings

Filing Released Lang Actions
Declaration of Final Dividend of Rs. 2.75 per equity share having face value of Re. 1/- each (i.e, 275%) for the FY 2023-24 for approval of members of the Company in the ensuing AGM pursuant ....
Regulatory Filings
2024-05-02 English
Dividend
Regulatory Filings
2024-05-02 English
Change in Management
Regulatory Filings Classification · 100% confidence The document text contains only a placeholder indicating an omitted picture and has a very short length (55 characters). There is no substantive content, no financial data, no announcements, or any textual information to classify. Given the absence of any meaningful content, the document cannot be classified as a specific report or announcement. According to the rules, such minimal content defaults to Regulatory Filings (RNS) as a fallback category.
2024-05-02 English
Financial and Segment wise results of the Company (Consolidated as well as standalone), for the year ended on March 31, 2024, Cash Flow Statement for the year ended March 31, 2024 and Statement ....
Regulatory Filings
2024-05-02 English
Publish Audited Results
Regulatory Filings
2024-05-02 English
Financial and Segment wise Results of the Company (Consolidated as well as Standalone) for the year ended on 31.03.2024, Cash Flow Statement for the year ended 31.03.2024 and Statement ....
Regulatory Filings
2024-05-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.